A Randomized Trial of Convalescent Plasma for COVID-19-Potentially Hopeful Signals

JAMA. 2020 Aug 4;324(5):455-457. doi: 10.1001/jama.2020.10218.

Authors

Arturo Casadevall¹, Michael J Joyner², Liise-Anne Pirofski³

Affiliations

¹ Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
² Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, Minnesota.
³ Montefiore Medical Center, Division of Infectious Diseases, Department of Medicine, Albert Einstein College of Medicine, Bronx, New York.

PMID: 32492105
DOI: 10.1001/jama.2020.10218

No abstract available

Publication types

Editorial
Comment

MeSH terms

Betacoronavirus*
COVID-19
COVID-19 Serotherapy
Coronavirus Infections* / therapy
Humans
Immunization, Passive
Pandemics*
Pneumonia, Viral*
SARS-CoV-2